From Risk Aversion to Real-World Impact: How Medtech Firms Can Harness AI
Shareholder Joelle Wilson discusses how medical device companies are exploring AI for regulatory purposes but face barriers such as risk aversion and regulatory challenges, and how, despite significant potential benefits, many firms hesitate to fully implement AI due to unclear regulations.